Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease

Lipid Disorders and Their Relevance to Outcomes in Chronic Kidney Disease

(2011) Nosratola D. Vaziri et al.   BLOOD PURIFICATION

Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression

(2011) Nosratola D. Vaziri et al.   Clinical and Experimental Nephrology

New Insights Into Lipid Metabolism in Chronic Kidney Disease

(2011) George A. Kaysen   JOURNAL OF RENAL NUTRITION

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

(2011) Colin Baigent et al.   LANCET

ApoA-1 Mimetic Peptide Reverses Uremia-Induced Upregulation of Pro-Atherogenic Pathways in the Aorta

(2010) Nosratola D. Vaziri et al.   AMERICAN JOURNAL OF NEPHROLOGY

HDL metabolism and activity in chronic kidney disease

(2010) Nosratola D. Vaziri et al.   Nature Reviews Nephrology

Atherosclerosis in CKD: differences from the general population

(2010) Tilman B. Drüeke et al.   Nature Reviews Nephrology

Reverse Cholesterol Transport Pathway in Experimental Chronic Renal Failure

(2009) Hamid Moradi et al.   AMERICAN JOURNAL OF NEPHROLOGY

In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide

(2009) Nosratola D. Vaziri et al.   KIDNEY INTERNATIONAL

Plasma phospholipid transfer protein, cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase in end-stage renal disease (ESRD)

(2009) M. V. Pahl et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis

(2009) Bengt C. Fellström et al.   NEW ENGLAND JOURNAL OF MEDICINE